Isotopia Molecular Imaging Ltd. (“Isotopia”) was incorporated in the second half of 2006 to provide radioactive isotopes to the growing sector of nuclear medicine in Israel. The vision of Isotopia is to become the leader in the field of molecular imaging and radiotherapy both as a dependable supplier to the existing market as well as through strategic research and development with academic and private laboratories as well as the pharmaceutical, medical devices and biotechnology companies.